Physician profile
Robert D Bibb
NPI 1144267261
$4,449.06
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,873 · 2020: $906 · 2021: $1,273 · 2022: $328 · 2023: $70.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $70.07.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $70.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $624.26 | 2019-2023 | Botox |
| Regeneron Healthcare Solutions, INC. | $459.41 | 2019-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $442.79 | 2019-2021 | |
| Amgen INC. | $394.76 | 2019-2022 | |
| Pfizer INC. | $373.56 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $358.51 | 2019-2023 | |
| Janssen Biotech, INC. | $355.04 | 2019-2022 | |
| Ucb, INC. | $307.63 | 2019-2022 | |
| Celgene Corporation | $262.60 | 2019 | |
| Sun Pharmaceutical Industries INC. | $232.38 | 2019-2022 | |
| Lilly USA, LLC | $164.62 | 2019-2021 | |
| Genentech USA, INC. | $136.48 | 2019-2022 | |
| Janssen Scientific Affairs, LLC | $110.00 | 2019-2021 | |
| Vyne Pharmaceuticals INC. | $60.68 | 2020 | |
| Leo Pharma INC. | $54.61 | 2021-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Helsinn Therapeutics (U.S.), INC. | $36.54 | 2021 | |
| Nabriva Therapeutics, Plc | $22.30 | 2021 | |
| Prugen, INC. Pharmaceuticals | $22.00 | 2020 | |
| Incyte Corporation | $18.86 | 2021 | |
| Mylan Pharmaceuticals INC. | $12.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Bibb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.